Table 1 Baseline Data of drug-induced autoimmune hepatitis patients reported in the FAERS database.
From: Real-world pharmacovigilance study of drug-induced autoimmune hepatitis from the FAERS database
Variables | Value |
|---|---|
Age (year) | 53.82 ± 18.43 |
Weight (Kg) | 69.4 ± 22.22 |
Gender | |
Female | 1488 (59.26%) |
Male | 754 (30.03%) |
Missing | 269 (10.71%) |
Outcomes | |
Other serious (Important Medical Event) | 1093 (43.53%) |
Hospitalization -initial or prolonged | 980 (39.03%) |
Disability | 15 (0.60%) |
Death | 213 (8.48%) |
Life-threatening | 114 (4.54%) |
Required intervention to prevent permanent impairment/damage congenital anomaly | 2 (0.08%) |
Missing | 94 (3.74%) |
Continents | |
Europe | 835 (49.64%) |
Asia | 285 (16.95%) |
North America | 198 (11.78%) |
Oceania | 192 (11.42%) |
South America | 127 (7.55%) |
Africa | 46 (2.73%) |
